Ftse Mib
35.366,20
0,00%
DAX
18.869,36
0,78%
S&P 500
5.308,15
1,17%
NASDAQ
16.742,39
1,40%
Bitcoin
65.821,80
-0,66%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Travere Therapeutics Inc (TVTX) Travere Therapeutics Inc (TVTX) Notizie

Travere Therapeutics Inc

TVTX
6,80
0,10 (1,49%)
16 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
15/5/202423:00GLOBETravere Therapeutics Reports Inducement Grants Under Nasdaq..
13/5/202422:05EDGAR2Form 8-K - Current report
10/5/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202422:30GLOBETravere Therapeutics to Present at National Kidney..
08/5/202422:30GLOBETravere Therapeutics to Present at Upcoming Investor..
06/5/202422:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/5/202422:05EDGAR2Form 8-K - Current report
06/5/202422:01GLOBETravere Therapeutics Reports First Quarter 2024 Financial..
29/4/202422:30GLOBETravere Therapeutics to Report First Quarter 2024 Financial..
24/4/202413:05GLOBETravere Therapeutics and CSL Vifor Announce European..
24/4/202409:00PRNCACSL Vifor and Travere Therapeutics Announce European..
04/4/202422:30GLOBETravere Therapeutics to Present Abstracts at the Society for..
03/4/202422:30GLOBETravere Therapeutics to Present Abstracts on FILSPARI®..
13/3/202422:00GLOBETravere Therapeutics Reports Inducement Grants Under Nasdaq..
11/3/202412:05GLOBETravere Therapeutics Submits Supplemental New Drug..
26/2/202422:30GLOBETravere Therapeutics to Present at Upcoming Investor..
23/2/202422:05EDGAR2Form 8-K - Current report
23/2/202413:05GLOBETravere Therapeutics and CSL Vifor Announce Sparsentan..
23/2/202408:00PRNCACSL Vifor and Travere Therapeutics announce sparsentan..
20/2/202414:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15/2/202422:05EDGAR2Form 8-K - Current report
15/2/202422:01GLOBETravere Therapeutics Reports Fourth Quarter and Full Year..
14/2/202420:35EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202422:30GLOBETravere Therapeutics to Report Fourth Quarter and Full Year..
02/2/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202403:58EDGAR2Form 144 - Report of proposed sale of securities
02/2/202403:58EDGAR2Form 144 - Report of proposed sale of securities
02/2/202403:57EDGAR2Form 144 - Report of proposed sale of securities
01/2/202422:30GLOBETravere Therapeutics to Present at the Guggenheim 6th Annual..
01/2/202418:44EDGAR2Form 144 - Report of proposed sale of securities
01/2/202415:52EDGAR2Form 144 - Report of proposed sale of securities
25/1/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202422:05GLOBETravere Therapeutics Announces Licensing Agreement with..
23/1/202419:17EDGAR2Form 144 - Report of proposed sale of securities
23/1/202416:51EDGAR2Form 144 - Report of proposed sale of securities
08/1/202413:07EDGAR2Form 8-K - Current report
Apertura: 6,93 Min: 6,78 Max: 7,19
Chiusura: 6,70

La tua Cronologia

NASDAQ
TVTX
Travere Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network